cytarabine has been researched along with Cholestasis, Intrahepatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, HJ; Cho, MS; Choi, MY; Kong, JH; Kwon, JM; Lee, KE; Lee, SM; Lee, SN; Mun, YC; Nam, E; Nam, SH; Seong, CM; Yoo, SH | 1 |
| Hashimoto, M; Hirose, S; Horie, S; Ishiyama, T; Saito, K; Seekikawa, I; Sugimoto, M; Wakabayashi, Y | 1 |
2 other study(ies) available for cytarabine and Cholestasis, Intrahepatic
| Article | Year |
|---|---|
Early imatinib-mesylate-induced hepatotoxicity in chronic myelogenous leukaemia.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bile Ducts; Blast Crisis; Chemical and Drug Induced Liver Injury; Cholestasis, Intrahepatic; Cytarabine; Drug Eruptions; Hepatocytes; Humans; Idarubicin; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver Function Tests; Male; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pyrimidines | 2007 |
[Acute leukemia complicated by hyperbilirubinemia due to high dose cytosine arabinoside therapy].
Topics: Cholestasis, Intrahepatic; Cytarabine; Humans; Hyperbilirubinemia; Leukemia, Promyelocytic, Acute; Male; Middle Aged | 1989 |